INTRODUCTIONMorbid obesity is a rapidly growing health problem all over the world. It threatens the life of different peoples and different age groups. 1 Bariatric surgery today is considered as the most effective way of management for persistent weight loss and for relieving the associated comorbidities and to improve the quality of life. 2 However, surgeons still have debates regarding the ideal weight loss procedure. Laparoscopic sleeve gastrectomy (LSG), which is one of the most popular bariatric surgery worldwide, has 2 serious complications leakage and bleeding from staple line with variable incidence ranging from 1.2 and 3.6 % respectively and can lead to serious outcome. 3,4 In an attempt to reduce these serious complications, another gastric restrictive technique came into view, notably, gastric plication that was first used as weight reducing procedure through an open approach. 5 Talebpour and Amoli were the first to perform the procedure through laparoscopy. 6 A ABSTRACT Background: Although laparoscopic sleeve gastrectomy (SLG) considered a gold standard way of management of morbid obesity, it still has serious complications as bleeding and staple line leak. Laparoscopic greater curvature plication (LGCP) was introduced as a trial gastric restrictive procedure and recently modified and standardized to obtain a gastric sleeve without resection and hence lower complications rates with the advantage of being a reversible procedure. Methods: 28 patients suffered from morbid obesity with body mass indices less than 50 kg/m 2 filling the selection criteria of the study were prepared for Stomach Sparing Gastric Sleeve (SSGS). After devascularization of the greater curvature, double in-folding of the greater curvature using non-absorbable 2-0 sutures starting at the angle of His to 3-4 cm proximal to the pylorus, were done. Results: 28 patients with preoperative mean total body weight (TBW) of 118.7±15.5 kg and a mean BMI of 38±6.5 kg/m 2 were the target of this study. The mean operative time was 103±11 min. Early minor postoperative complications were detected in 18 patients (64%) and included nausea, vomiting and sialorrhea. Postoperative reflux esophagitis was detected in 2 patients (7%). Postoperative % EWL (excess weight loss) was 32.2% at 1 month, 48.9% at 3 months, 53.3% at 6 months, 66.7% at 12 months and 70.2% at 15 months. The improvement of the pre-existent co-morbidities occurred in 7 patients (53.8%). Conclusions: SSGS is a promising low cost restrictive bariatric operation. It is reversible and effective weight losing procedure in the short term.